Fátima Marín (@FatimaMarinn) profile picture

Researcher at Hereditary Cancer group. IDIBELL

Joined May 2023
bioRxiv has a dedicated section for negative results. Use it. Share negative results. Your colleagues will appreciate it.
19
383
30
1,901
187,261
New #JITC article: Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies bit.ly/3EiJBUN @jcastilloiturra @mariapellise1 @MoreiraR_Leti @merydacaalvarez @MartaPinedaRiu @frankbalaguer @hospitalclinic @idibell_cat
16
18
1,442
La síndrome de Lynch augmenta el risc de tenir càncer d'endometri. La recerca que lidera Gabriel Capellà, de l'@ICO_oncologia - @idibell_cat, vol personalitzar la prevenció d'aquest càncer mitjançant l'empoderament de la dona en la presa de decisions dels tractaments
1
3
6
1,145
🚨𝗪𝗲 𝗮𝗿𝗲 𝗵𝗶𝗿𝗶𝗻𝗴! We are looking for a #bioinformatician to join our group at @idibell_cat! Work with NGS & omic analyses. More about us: bit.ly/3DtvJ9M ➡️ Collaborative research ➡️ Projects in hereditary cancer ‼️Info & applications👇 bit.ly/4iI9gVe
3
2
201
Fátima Marín retweeted
We are hiring! Looking for a postdoctoral researcher to work on pancreatic cancer modelling. A joint collaboration between hereditarycancergroup.com and p-cmrc.cat/research/rovira-g… @idibell_cat Job application link: idibell.fundanetsuite.com/co…
7
1
12
952
Fátima Marín retweeted
Researchers develop and optimize the hs-MSI genetic test🧬, which will improve #CMMRD diagnosis, a rare cancer predisposition in children. This tool will also help refine their clinical prognosis, making them candidates to #immunotherapy Read more 👉 idibell.cat/en/2024/07/a-gen…
3
14
820
Fátima Marín retweeted
How do mismatch repair-deficient (MMRd) cancers trade off the evolutionary costs and benefits of elevated mutation rates? Delighted to share our paper on adaptive mutability in MMRd colorectal cancer (CRC) @NatureGenet nature.com/articles/s41588-0… Tweetorial 🧵below
6
26
6
79
30,308
Fátima Marín retweeted
I am SUPER thrilled to announce that we have launched the Network for Rare Tumors of the Ovary website!!! A community meeting point for Patients, Researchers, Advocates and Clinicians interested in Rare Ovarian Tumors like SCCOHT and SCSTs. The NRTO explained in a thread:
3
19
3
38
2,799
#InSiGHT2024 in Barcelona has just finished. We have had really good science and fun! Very proud of @FatimaMarinn and @elisabetmunte presentations on CMMRD in Spain and open-source PMS2 pipeline. See you all in Singapore! @idibell_cat @ICO_oncologia
6
24
916
Fátima Marín retweeted
Harvard is offering free research courses. No fees are required. Here are 9 courses you don't want to miss:
21
895
28
3,232
650,889
🔥 Highly sensitive microsatellite instability assay is a robust ancillary test for Constitutional Mismatch Repair Deficiency diagnosis, able to distinguish PMS2 biallelic carriers. @idibell_cat @ICO_oncologia @MartaPinedaRiu @FatimaMarinn #MedTwitter 👇 buff.ly/4adStVk
4
1
5
1,145
Very happy to share with you our last publication on CMMRD! Thank you very much to Fátima Marín, Julia Canet-Hermida and our great collaborators! #hereditarycancer #CMMRD @Uri_Tabori @ICO_oncologia @idibell_cat
🔥 Highly sensitive microsatellite instability assay is a robust ancillary test for Constitutional Mismatch Repair Deficiency diagnosis, able to distinguish PMS2 biallelic carriers. @idibell_cat @ICO_oncologia @MartaPinedaRiu @FatimaMarinn #MedTwitter 👇 buff.ly/4adStVk
1
6
12
737